Skip to content

Resistance Exercise Training in Chronic Kidney Disease

Effect of Resistance Exercise Training on Endothelial Function and Cardiovascular Risk Factors in Patients With Chronic Kidney Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03120416
Enrollment
34
Registered
2017-04-19
Start date
2017-01-25
Completion date
2018-07-31
Last updated
2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Brief summary

The investigators aim to evaluate the feasibility of a resistance exercise training program among individuals with CKD and its impact on endothelial and vascular function.

Detailed description

Resistance exercise training has been shown to improve cardiovascular health including endothelial function in general populations, but studies in patients with chronic kidney disease (CKD) are limited. The investigators aim to evaluate the feasibility and acceptability of a resistance exercise training program among individuals with CKD and its impact on endothelial and vascular function as measured by brachial artery flow-mediated dilation, pulse-wave velocity and carotid artery stiffness. To accomplish this goal the investigators propose to conduct a 12-week pilot randomized controlled trial of twice a week resistance exercise training among 32 adults with CKD. The results of this study will inform the design and implementation of a larger trial evaluating the impact of resistance exercise training on adverse outcomes in patients with CKD including CKD progression.

Interventions

BEHAVIORALResistance exercise training

12-week resistance exercise training program, 2 times per week, 45 min per session. Eight exercises will be used to include large upper and lower body muscle groups (leg press, leg extension, leg curl, chest press, shoulder extension, biceps curl, abdominal crunch and back extension). The baseline one repetition maximum will be used to set initial training loads.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* CKD stage 3 or 4 (eGFR 15-60 ml/min/1.73m2)

Exclusion criteria

* Currently institutionalized * Kidney transplant or dialysis * NY Heart Association class 3-4 heart failure * Dementia or cognitive impairment * Unstable angina or coronary revascularization within the last 3 months * Uncontrolled arrhythmia * Severe chronic lung disease * Orthopedic, neurologic or other condition that would preclude resistance exercise training * Pregnancy * Uncontrolled hypertension (systolic \> 160 mmHg and diastolic \>90 mmHg)

Design outcomes

Primary

MeasureTime frameDescription
Endothelial function3 monthsMeasured by brachial artery flow-mediated dilation (FMD)

Secondary

MeasureTime frameDescription
Carotid artery stiffness3 monthsMeasured by non-invasive ultrasound
Self-reported physical activity3 monthsAssessed by the MESA (Multiethnic Study of Atherosclerosis) Typical Week Physical Activity Survey
Objectively measured physical activity3 monthsAssessed by a physical activity monitor (ActiGraph GT3X+)
Vascular function3 monthsMeasured by pulse wave velocity
Serum LDL-cholesterol3 monthsMeasured using standard procedures
Serum HDL-cholesterol3 monthsMeasured using standard procedures
Muscle strength3 monthsAssessed by the amount of weight lifted in a single chest press and leg press (1 RM).
Systolic blood pressure3 monthsMeasured using standard procedures

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026